When catheter manufacturers evaluate process improvements, the conversation typically starts with a simple question: “How much can we save on labor?” But the reality is that labor-only justification rarely drives meaningful returns with high-risk medical device manufacturing. The true ROI comes from addressing bottlenecks in quality, yield, and throughput, as well as the hidden costs of scrap.
Why Labor-Only ROI Falls Short
When you factor in the capital investments and equipment required to enable large-scale process optimizations, it’s difficult to justify a new approach based solely on labor reduction — even if your complex catheter requires thousands of workers on the line.
However, labor dynamics are shifting. Wage increases are accelerating even in regions where labor is traditionally inexpensive, such as Costa Rica and Mexico, and labor constraints are a critical issue.
Key Challenges with Labor-Focused ROI:
- Labor costs in low-cost manufacturing regions remain competitive, making major capital expenditures hard to justify on savings alone
- Decision-makers tend to be deliberately conservative in their financial underwriting for improvement projects
- Many manufacturers need high-volume production, but catheters vary significantly in sizes and configurations, creating operational complexity
Beyond labor economics, manual assembly introduces variability that impacts your bottom line. Even with highly trained operators, human factors such as eye strain during inspection, fatigue, operator turnover, and inconsistent technique lead to yield losses that directly affect profitability. And without real-time monitoring and component feedback, variation compounds across production steps.
The Real Cost of Scrap & Production Bottlenecks
Depending on where failure occurs in the manufacturing process, scrap can represent up to $10k in lost value — particularly for diagnostic and therapeutic catheters with complex assemblies, sensors, and embedded electronics.
Common Defect Types in Catheter Manufacturing:
- Bends, kinks, and scratches from handling
- Braid coating inconsistencies
- Contamination from debris or foreign materials (FM)
- Weld or UV glue bonding defects at device ends
- Tip bonding failures
- Surface irregularities that affect device performance
- Electrical test failures for sensor mapping and CPU chip verification
4 Common Production Bottlenecks:
- Inspection: Time-intensive and prone to inconsistency
- Bonding: Requires precision and process control
- Tip forming: Shaping and finishing catheter tips to exact specifications
- Final assembly: Multi-step processes where manual handling introduces risk
Scrap rates are often highest during ramp-up, which can delay time-to-market and erode margins before production stabilizes. For startups and companies scaling novel product concepts into commercial production, hidden costs can also add up.
Hidden Costs Beyond Raw Materials:
- Lost production time due to rework and supplemental inspection cycles
- Complex investigations to diagnose microscopic defects and component issues
- Training overhead: Catheter assembly manufacturing can require up to 9 months of training
- Component batch risk: While complex catheters aren’t typically batch-built, component issues (like glue batches) can threaten entire production runs
- Future product changes: As products evolve, manufacturers need flexible assembly systems that can accommodate component changes without complete redesigns
The Real Hurdle Isn’t Just Cost. It’s Revalidation.
Any process change that touches the catheter, not just inspection equipment, requires revalidation per FDA, EU MDR, or other applicable regulatory requirements. Operational Qualification (OQ) and Performance Qualification (PQ) can take manufacturers anywhere from 6 months to 1.5 years.
Output stability also matters significantly for capacity planning and revenue-per-square-foot calculations — and is especially critical for new product introductions (NPI).
How to Approach Process Automation Strategically
Depending on organizational readiness and throughput goals, not every catheter manufacturer needs the same level of process intervention.
When Semi-Automation Makes Sense:
- Product designs are still evolving and require flexibility
- Production volumes don’t yet justify major capital expenditure
- Multiple SKUs with significant variation in assembly steps
- Limited in-house technical engineering expertise or support infrastructure
Signals You’re Ready for Systemic Transformation:
- Clear bottlenecks that incremental changes can’t address
- Willingness to invest in higher-skilled personnel or partner with technical support providers
- Ability to write User Requirement Specifications (URS) and detailed process specs
- Commitment to building a long-term operational strategy beyond individual equipment purchases
Critical Readiness Questions:
- Are local service resources available, or can remote support bridge the gap?
- Can your organization train and retain personnel capable of supporting advanced systems and operational standards at line speed?
- Have you mapped which processes work well, which don’t, and how to systematically address needs across your production line?
Building the Business Case: Metrics That Matter
If you’re trying to justify catheter manufacturing process improvements internally, leadership often needs to see ROI beyond labor savings. An integrated partner can help you evaluate custom automation needs and build a business case that’s realistic for your organization’s goals and priorities.
For NPI, the conversation shifts from “what will we save?” to “how quickly can we scale production while maintaining the quality critical for patient safety?” By optimizing processes and integrating automated software and interconnected hardware, manufacturers can shorten their time-to-launch, ensure their equipment and designs are ready to withstand regulatory scrutiny, and expand quality assurance capabilities.
What To Look for in Technical Partners and Contract Manufacturers:
- Relevant experience: Deep technical knowledge in complex medical device manufacturing, materials handling, vision systems, custom tooling, and catheter-specific processes
- Active listening and risk tracking: Partners who understand what works, what doesn’t, and how to address challenges proactively
- R&D collaboration capability: Rare but valuable — partners who can work with decision-makers early in early product development stages to ensure Design for Manufacturing (DfM) principles are embedded from the start
- Engineering support: Third-party experts who can provide actionable product recommendations to reduce scrap and optimize workflows during production ramp-up
By engaging manufacturing expertise during R&D, you can create custom upstream solutions that prevent costly redesigns later and significantly reduce time-to-market. In the competitive catheter manufacturing landscape, this advantage can be the difference between capturing market share early and playing catch-up.
Work with Ascential to maximize your ROI. Our multidisciplinary experts can support your entire manufacturing lifecycle, from project-specific automation and precision manufacturing to supply chain management. Let’s discuss how we can bring your catheter product to market with confidence.